A PYMNTS Company

US Appeals Court to Hear Impax’s Bid to Overturn FTC Antitrust Order

By  |  March 19, 2020

A federal appeals court will hear pharmaceutical maker Impax Laboratories LLC’s bid to overturn a 2019 antitrust order imposed by the Federal Trade Commission.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The U.S. Court of Appeals for the Fifth Circuit scheduled April 27 arguments in a case brought by the FTC that accuses Impax of illegally blocking access to a generic extended release pain reliever.

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Full Content: Bloomberg

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.